The purpose of this study is to investigate FebriDx, a point-of-care, non-invasive, rapid diagnostic test, at identifying an immune response to viral and bacterial infection related to an acute community acquired febrile upper respiratory infection, as compared to expert clinical reviewers' evaluation in conjunction with the results of clinical standardized microbiologic and laboratory testing.